Article thumbnail

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases

By S. J. Chittenden, C. Hindorf, C. C. Parker, V. J. Lewington, B. E. Pratt, B. Johnson and G. D. Flux
Publisher: Society of Nuclear Medicine
Year: 2015
DOI identifier: 10.2967/jnumed.115.157123
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.